You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

decitabine

Showing 1 - 25 of 192
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • decitabine
  • +4 more
  • (no location specified)
Dec 29, 2022

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)

Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Decitabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

Recruiting
  • Myelodysplastic Syndromes
  • MDS/MPN Crossover Syndromes
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Acute Myeloid Leukemia Trial in Columbus (Decitabine, Nivolumab, Venetoclax)

Suspended
  • Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 5, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

Recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022

Leukemia Trial in Houston (Vosaroxin, Decitabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 13, 2022

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Decitabine
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Pancreatic Ductal Adenocarcinoma, Sarcoma Trial in Iowa City (Decitabine, Gemcitabine)

Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Dec 3, 2021

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
Sep 23, 2021

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Decitabine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

Solid Tumor Trial in Los Angeles, Baltimore (Decitabine, Cedazuridine)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +1 more
Nov 18, 2021

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Decitabine
  • +3 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 22, 2023

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Feb 16, 2022

Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)

Recruiting
  • Recurrent Leukemia
  • Refractory Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 11, 2021

ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)

Terminated
Has Results
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
Sep 18, 2021

Engraft Failure, Relapse, GVHD Trial (decitabine, Acetylcysteine, Semustine)

Not yet recruiting
  • Engraft Failure
  • +2 more
  • decitabine
  • +8 more
  • (no location specified)
Jun 22, 2021

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022